FOXO1 respectively inhibits and enhances eNOS and inducible-NOS (iNOS), contributing to pro-atherogenic effects, as confirmed by the reduced progression of atherosclerosis in FOXO1-deleted mouse models [71, 72]. This evidence concerns the gene NOS3 and atherosclerosis.